Barclays has initiated coverage on DENTSPLY SIRONA Inc (XRAY) with an Underweight rating, marking the firm's first assessment of the company. This action, effective December 8, 2025, comes as DENTSPLY SIRONA trades at $11.71 per share.
Headquartered in Charlotte, North Carolina, DENTSPLY SIRONA engages in the design, manufacture, sales, and distribution of professional dental products and technologies. The company has a market capitalization of $2.3 billion and employs approximately 14,000 people. Its product offerings span various segments, including Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.
As of December 1, 2025, the analyst consensus on DENTSPLY SIRONA indicates 3 Strong Buy, 4 Buy, 14 Hold, and no Sell or Strong Sell ratings, reflecting a consensus rating of Hold. Upcoming earnings are scheduled for August 5, 2026, with an estimated EPS of $0.48 and revenue of $957.1 million.
Analyst ratings serve as professional opinions based on extensive research and financial modeling. While they can provide valuable insights, they are based on assumptions that may not always materialize. Investors should consider a range of factors, including company fundamentals and industry trends, when making investment decisions.